November 13-16, 2007, Annop connived or agreed with Kamthorn to trade RS shares in a manner that inflated and stabilized the share price in concealment to mislead the public to believe in the artificially
their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve
their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve
decrease of Baht 42.95 million or down by 7.19% due to the shift of joint marketing activities with suppliers to the second half of this year. 2. Gross profit was Baht 3,847.69 million, an increase of Baht
decrease of Baht 42.95 million or down by 7.19% due to the shift of joint marketing activities with suppliers to the second half of this year. 2. Gross profit was Baht 3,847.69 million, an increase of Baht
Initial Public Offering (IPO) and its first day trade under “BAM” on 16 December 2019. The overall IPO shares are as follows: 1. Up to 280,000,000 new common shares for the IPO 2. Up to 1,255,000,000 common
company’s Initial Public Offering (IPO) and its first day trade under “BAM” on 16 December 2019. The overall IPO shares are as follows: 1. Up to 280,000,000 new common shares for the IPO 2. Up to
: ประกาศ COI และประกาศเกี่ยวกับการลงทุน เพื่อเป็นทรัพย์สินของผู้ประกอบธุรกิจ: ประกาศ Prop Trade ) ซึ่งได้มีการพิจารณาปรับปรุงแก้ไข ร่างประกาศในประเด็นอื่น ๆ เพิ่มเติมเพื่อให้มีความเหมาะสมยิ่งขึ้นด้วย
Highlights on Financial Position Unit : Million Baht 30 Jun 18 31 Dec 17 %Change Cash and Cash equivalents 15,607 17,320 (9.9) Trade and other receivables 11,310 10,468 8.0 Inventories 8,480 7,684 10.4
and 1.11 in last quarter. Highlights on Financial Position Unit : Million Baht 30 Sep 18 31 Dec 17 %Change Cash and Cash equivalents 16,403 17,320 (5.3) Trade and other receivables 11,268 10,468 7.6